Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

A prophylactic antibody-based immune therapy has been shown to protect monkeys against severe bird flu caused by H1N1.

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

Scientists are concerned that bird flu may eventually mutate so that it can readily spread among people – something it cannot ...

The Mail has recruited leading virologists, epidemiologists and pandemic planners to imagine the kind of scenario that might ...

New cases of HPAI have been identified in the wild bird populations of 13 European countries over past two weeks.

The unidentified Brit, thought to be from the West Midlands, is believed to have contracted it on a farm, where they had ...

The H5N1 virus has a ways to go before it can successfully jump to humans but that it doesn’t reduce the threat it poses.

The Centers for Disease Control and Prevention are monitoring the bird flu situation in the United States. Here's what to ...